ArticleBioData mining2025
Leveraging mixed-effects regression trees for the analysis of high-dimensional longitudinal data to identify the low and high-risk subgroups: simulation study with application to genetic study.
Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence virtual extracellular vesicles (AIVEVs).Bioactive materials · 2026Review
- Development and validation of a model to predict the progression of Alzheimer's disease.Age and ageing · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe linear mixed-effects model (LME) is a conventional parametric method mainly used for analyzing longitudinal and clustered data in genetic studies. Previous studies have shown that this model can be sensitive to parametric assumptions and provides less predictive performance than non-parametric methods such as random effects-expectation maximization (RE-EM) and unbiased RE-EM regression tree algorithms. These longitudinal regression trees utilize classification and regression trees (CART) and conditional inference trees (Ctree) to estimate the fixed-effects components of the mixed-effects model. While CART is a well-known tree algorithm, it suffers from greediness. To mitigate this issue, we used the Evtree algorithm to estimate the fixed-effects part of the LME for handling longitudinal and clustered data in genome association studies.
methodsIn this study, we propose a new non-parametric longitudinal-based algorithm called "Ev-RE-EM" for modeling a continuous response variable using the Evtree algorithm to estimate the fixed-effects part of the LME. We compared its predictive performance with other tree algorithms, such as RE-EM and unbiased RE-EM, with and without considering the structure for autocorrelation between errors within subjects to analyze the longitudinal data in the genetic study. The autocorrelation structures include a first-order autoregressive process, a compound symmetric structure with a constant correlation, and a general correlation matrix. The real data was obtained from the longitudinal Tehran cardiometabolic genetic study (TCGS). The data modeling used body mass index (BMI) as the phenotype and included predictor variables such as age, sex, and 25,640 single nucleotide polymorphisms (SNPs).
resultsThe results demonstrated that the predictive performance of Ev-RE-EM and unbiased RE-EM was nearly similar. Additionally, the Ev-RE-EM algorithm generated smaller trees than the unbiased RE-EM algorithm, enhancing tree interpretability.
conclusionThe results showed that the unbiased RE-EM and Ev-RE-EM algorithms outperformed the RE-EM algorithm. Since algorithm performance varies across datasets, researchers should test different algorithms on the dataset of interest and select the best-performing one. Accurately predicting and diagnosing an individual's genetic profile is crucial in medical studies. The model with the highest accuracy should be used to enhance understanding of the genetics of complex traits, improve disease prevention and diagnosis, and aid in treating complex human diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.